AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 6129609
Drug: Combined salbutamol-dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Combined salbutamol-dexamethasone treatment
Trial: 27587605
Drug: MCO CC
RxNorm normalized name: MCO-010
DrugBank: Sonpiretigene isteparvovec (DB17844)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MCO CC
Trial: 18270526
Drug: Food items
RxNorm normalized name: ALLERGENIC EXTRACT, FOOD, WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Food items enriched with mineral nutrients and 1.25, 2.5, and 5.0 g per day of plant sterols during the first, second, and third 5-week periods, respectively
Trial: 26228214
Drug: Total Parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total Parenteral Nutrition (TPN)
Trial: 15974216
Drug: Colgate Winterfresh
RxNorm normalized name: Colgate
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Colgate Winterfresh Gel (CWG)
Trial: 2187665
Drug: Captopril (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (50 mg, single oral dose)
Trial: 29098257
Drug: Oral implantation
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral implantation
Trial: 12667600
Drug: Polyphenol-rich juice
RxNorm normalized name: tamarind juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyphenol-rich juice A (236 mg polyphenols, cyanidin glycosides)
Trial: 12667600
Drug: Polyphenol-rich juice
RxNorm normalized name: tamarind juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyphenol-rich juice B (226 mg polyphenols, epigallocatechin gallate)
Trial: 8795441
Drug: gamma‐L‐glutamyl‐L‐3,4‐dihydroxyphenylalanine (gludopa)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gamma‐L‐glutamyl‐L‐3,4‐dihydroxyphenylalanine (gludopa)
Trial: 8795441
Drug: gamma‐L‐glutamyl‐5‐hydroxy‐L‐tryptophan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gamma‐L‐glutamyl‐5‐hydroxy‐L‐tryptophan
Trial: 6372934
Drug: Cholecystokinin (CCK)
RxNorm normalized name: cholecystokinin
DrugBank: Cholecystokinin (DB08862)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecystokinin (CCK) infusion (1 Ivy Dog Unit/kg over 5 min)
Trial: 3714912
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline (placebo) infusion
Trial: 6372934
Drug: Repeat CCK
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeat CCK infusion postoperatively
Trial: 18519174
Drug: Risedronate (RIS),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate (RIS), 35 mg once weekly
Trial: 7485479
Drug: L-[3,4-3H]glutamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-[3,4-3H]glutamine infusion
Trial: 1826739
Drug: Ondansetron 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 0.15 mg/kg IV every 4 hours for three doses
Trial: 1826739
Drug: Metoclopramide 2
RxNorm normalized name: metoclopramide 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 2 mg/kg IV every 2 hours for three doses, then every 3 hours for three additional doses
Trial: 17425814
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (recommended induction dose of propofol)
Trial: 8186380
Drug: Hyoscine N-butyl
RxNorm normalized name: n-butyl acrylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyoscine N-butyl bromide (20 mg)
Trial: 8186380
Drug: Propinoxate (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propinoxate (5 mg) plus diazepam
Trial: 2951570
Drug: Clindamycin phosphate
RxNorm normalized name: Clindamycin Phosphate
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clindamycin phosphate (1% solution)
Trial: 2951570
Drug: Tetracycline (solution)
RxNorm normalized name: Tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetracycline (solution)
Trial: 20234000
Drug: Web administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Web administration of the Youth Risk Behavior Survey (YRBS)
Trial: 20234000
Drug: Paper-and-pencil administration
RxNorm normalized name: paper birch pollen extract
DrugBank: Betula papyrifera pollen (DB10831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paper-and-pencil administration of the Youth Risk Behavior Survey (YRBS)
Trial: 18567678
Drug: mct/lct-propofol with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mct/lct-propofol with lidocaine 10 mg/ml
Trial: 7719761
Drug: Methylprednisolone (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (3 mg/kg in saline)
Trial: 31145226
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) ketorolac
Trial: 27763895
Drug: Low urine
RxNorm normalized name: Urin DS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low urine output target of 0.2 mL/kg/h
Trial: 27763895
Drug: Standard urine
RxNorm normalized name: Urin DS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard urine output target of 0.5 mL/kg/h
Trial: 24565620
Drug: Attention control
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Attention control group (ATG) with weekly meetings with a research assistant and mp3 physician-recorded asthma messages
Trial: 19735398
Drug: Cotton blanket
RxNorm normalized name: Cotton
DrugBank: Cotton (DB10707)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cotton blanket with saline injection
Trial: 15161075
Drug: Rectal vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal vaccination with cholera toxin B subunit
Trial: 15161075
Drug: Oral vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vaccination with cholera toxin B subunit
Trial: 11484451
Drug: Josamycin 50
RxNorm normalized name: josamycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Josamycin 50 mg.kg‐1.day‐1 b.i.d for 5 days
Trial: 9656557
Drug: Single nightly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single nightly prophylactic dose of an antibiotic
Trial: 9656557
Drug: Single nightly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single nightly prophylactic dose of an antibiotic and oxybutinin as in group II
Trial: 7914462
Drug: Adjunctive bilateral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive bilateral electroconvulsive therapy (ECT)
Trial: 31475497
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Fuyang-pot warming and EA
Trial: 21668442
Drug: Lead time
RxNorm normalized name: lead
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lead time to treatment
Trial: 16307711
Drug: Concurrent task
RxNorm normalized name: stannous fluoride
DrugBank: Stannous fluoride (DB11092)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent task of randomly generating months of the year aloud (dual-task condition)
Trial: 3948545
Drug: Caffeine (7.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (7.2 mg/kg)
Trial: 16505224
Drug: Rosiglitazone (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone (8 mg for 4 months)
Trial: 15291903
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment group (acupuncture and Chinese herbal medicine)
Trial: 11815726
Drug: 0.625 mg
RxNorm normalized name: estrone 0.625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg conjugated equine estrogen (CEE) and 2.5 mg medroxyprogesterone acetate (MPA) every other day
Trial: 14676459
Drug: 0.625 mg
RxNorm normalized name: estrone 0.625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg CEE and 2.5 mg MPA every day
Trial: 11815726
Drug: Low estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low estradiol group (<15 pg/ml)
Trial: 11815726
Drug: Middle estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Middle estradiol group (>=15 and <25 pg/ml)
Trial: 11815726
Drug: High estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High estradiol group (>=25 pg/ml)
Trial: 9794022
Drug: Cognitive and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive and behaviour therapy
Trial: 8435693
Drug: Self-help treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-help treatment programme
Trial: 20608035
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of lascropuncture infrared radiation and manual therapy
Trial: 15225178
Drug: Lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 30 mg/day
Trial: 15225178
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg/day
Trial: 21735688
Drug: Transdermal 17beta-estradiol
RxNorm normalized name: Estradiol-17beta
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal 17beta-estradiol (Oesclim 50) combined with oral norethisterone 2.5 mg daily (Primolut-Nor)
Trial: 21735688
Drug: Oral 2
RxNorm normalized name: SYRINGE,ORAL 20ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral 2 mg 17beta-estradiol combined with oral 1 mg daily norethisterone (Kliogest)
Trial: 19902046
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (Control Group C)
Trial: 16302558
Drug: Azelaic acid
RxNorm normalized name: Azelaic Acid
DrugBank: Azelaic acid (DB00548)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Azelaic acid 15% gel
Trial: 15176158
Drug: Benzoyl peroxide/clindamycin
RxNorm normalized name: BENZOYL PEROXIDE/CLINDAMYCIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzoyl peroxide/clindamycin gel
Trial: 11753747
Drug: Conventional tricyclic
RxNorm normalized name: TRICYCLIC ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional tricyclic antidepressants
Trial: 25316463
Drug: Implant-retained mandibular
RxNorm normalized name: betaine
DrugBank: Betaine (DB06756)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Implant-retained mandibular overdentures
Trial: 9926766
Drug: All treatment
RxNorm normalized name: UNDECYLENIC ACID 8 g in 30 mL / TOLNAFTATE 1 g in 30 mL TOPICAL LIQUID [Fugal nall treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All treatment modalities
Trial: 31222540
Drug: 125 mg
RxNorm normalized name: niacin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 125 mg methylprednisolone intravenously on the induction of anaesthesia
Trial: 29034453
Drug: AVP-825 (22
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AVP-825 (22 mg sumatriptan nasal powder)
Trial: 25567657
Drug: Olanzapine 10
RxNorm normalized name: olanzapine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine 10 mg orally for 8 days + Ondansetron 8 mg intravenously 30 min before chemotherapy
Trial: 25567657
Drug: Ondansetron 8
RxNorm normalized name: ondansetron 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 8 mg intravenously 30 min before chemotherapy
Trial: 7611577
Drug: Control (rectal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (rectal paracetamol after operation before extubation)
Trial: 2698435
Drug: roxithromycin (RXT)
RxNorm normalized name: roxithromycin
DrugBank: Roxithromycin (DB00778)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: roxithromycin (RXT) 300 mg/day orally for an average of 9 days
Trial: 2698435
Drug: antibiotic/s (ATB)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: antibiotic/s (ATB) based on identified microorganisms, mean duration of treatment 12 days
Trial: 31675299
Drug: Cruciate-Retaining (CR)
RxNorm normalized name: Gentiana cruciata root extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cruciate-Retaining (CR) implant
Trial: 23789453
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment including melatonin
Trial: 16839346
Drug: BIBT 986
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BIBT 986 intravenous infusion
Trial: 12637979
Drug: Granulocyte‐Colony Stimulating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte‐Colony Stimulating Factor (G‐CSF) 5 microg/kg daily for 10 days
Trial: 10636257
Drug: Twice daily
RxNorm normalized name: CAPSULE, TWICE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice daily metoprolol tartrate (MT)
Trial: 10636257
Drug: Once daily
RxNorm normalized name: GEL, ONCE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once daily metoprolol succinate (MS)
Trial: 9020417
Drug: Antihistamine (mizolastine)
RxNorm normalized name: Ahist Antihistamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihistamine (mizolastine)
Trial: 9020417
Drug: Azelastine (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine (oral application)
Trial: 1527296
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose intravenous deslanoside (0.002 mg/kg body weight)
Trial: 1527296
Drug: 0.6 mg
RxNorm normalized name: thymol 0.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 mg of deslanoside (open label assessment)
Trial: 1527296
Drug: Deslanoside (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deslanoside (both doses)
Trial: 7720153
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no medication)
Trial: 29352518
Drug: Continuous wound
RxNorm normalized name: Uniphyllin Continus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous wound infusion (CWI) of 0.2% ropivacaine at 10 ml/h for 48 hours
Trial: 24251363
Drug: Genotype-guided dosing
RxNorm normalized name: dengue virus live antigen, CYD serotype 1 / dengue virus live antigen, CYD serotype 2 / dengue virus live antigen, CYD serotype 3 / dengue virus live antigen, CYD serotype 4 Injection [Dengvaxia]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genotype-guided dosing of warfarin
Trial: 24251361
Drug: Clinically guided
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinically guided dosing of warfarin
Trial: 16778691
Drug: Cervical epidural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cervical epidural steroid injections at C7-T1
Trial: 11434595
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg once daily, amoxycillin 750 mg three times a day, metronidazole 500 mg three times a day (RAM)
Trial: 3286439
Drug: Exifone 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exifone 600 mg/d
Trial: 3286439
Drug: Exifone 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exifone 1200 mg/d
Trial: 29561282
Drug: Postoperative 5-fluorouracil-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative 5-fluorouracil-based adjuvant therapies
Trial: 8942248
Drug: Chloral 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloral 40 mg/kg
Trial: 2240505
Drug: Trimeprazine 3
RxNorm normalized name: trimeprazine 30 MG per 5 ML Syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimeprazine 3 mg/kg
Trial: 2936269
Drug: Midazolam 0.2
RxNorm normalized name: midazolam 0.2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.2 mg/kg
Trial: 7138721
Drug: Sitting position
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitting position for 2.5 min or more during and after injection of 3 ml of 0.5% isobaric bupivacaine‐HCl
Trial: 30718952
Drug: Indacaterol/glycopyrronium (IND/GLY)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indacaterol/glycopyrronium (IND/GLY) 110/50 µg once daily for 16 weeks
Trial: 18808404
Drug: Standard-of-care immunosuppression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-of-care immunosuppression (Thymoglobulin and/or pulse steroids)
Trial: 17134488
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose intravenous furosemide 40 mg (Group 1)
Trial: 17134488
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose intravenous furosemide 120 mg (Group 2)
Trial: 12945021
Drug: Topical amitriptyline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical amitriptyline 50 mmol/L
Trial: 12945021
Drug: Topical amitriptyline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical amitriptyline 100 mmol/L
Trial: 12945021
Drug: Topical amitriptyline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical amitriptyline 10 mmol/L
Trial: 12945021
Drug: Topical amitriptyline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical amitriptyline
Trial: 2064495
Drug: Niacin 2000
RxNorm normalized name: Niacin
DrugBank: Niacin (DB00627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niacin 2000 mg
Trial: 20855072
Drug: Niacin 1500
RxNorm normalized name: Niacin
DrugBank: Niacin (DB00627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niacin 1500 mg
Trial: 2064495
Drug: Placebo and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo and diet treatment
Trial: 24827136
Drug: Mitomycin C
RxNorm normalized name: Mitomycin C
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin C without maintenance chemotherapy (MMC/No-maint)
Trial: 24827136
Drug: Cisplatin without
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin without maintenance chemotherapy (CisP/No-maint)
Trial: 15877562
Drug: Drug treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug treatment (oxybutynin IR titrated from 2.5 mg per day to 5.0 mg three times a day)
Trial: 10499828
Drug: Na2 ethylenediaminetetraacetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Na2 ethylenediaminetetraacetic acid (edta) solution
Trial: 1643676
Drug: Midazolam 0.5
RxNorm normalized name: midazolam 0.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.5 mg.kg‐1
Trial: 1659494
Drug: Lisinopril (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril (10 to 40 mg QD)
Trial: 1659494
Drug: Sustained-release verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release verapamil (120 to 480 mg QD)
Trial: 10657866
Drug: Intravenous ceftriaxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ceftriaxone
Trial: 11112678
Drug: Oral cefixime
RxNorm normalized name: Cefixime
DrugBank: Cefixime (DB00671)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral cefixime
Trial: 29503075
Drug: Intravenous levofloxacin
RxNorm normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous levofloxacin
Trial: 27034958
Drug: n-3 PUFA
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 PUFA supplementation at 3 g/d for 8 weeks
Trial: 25144625
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose of 50-60 min of aerobic exercise
Trial: 1948517
Drug: Ceftriaxone 250
RxNorm normalized name: ceftriaxone 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone 250 mg IM
Trial: 15683433
Drug: Nizatidine 150
RxNorm normalized name: nizatidine 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nizatidine 150 mg b.i.d.
Trial: 2892255
Drug: Nizatidine 25
RxNorm normalized name: nizatidine 25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nizatidine 25 mg b.i.d.
Trial: 20078514
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium suppository
Trial: 25260983
Drug: Acetaminophen suppository
RxNorm normalized name: acetaminophen Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen suppository
Trial: 25260983
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no analgesic)
Trial: 21797795
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of angiotensin II receptor antagonist (ARB) and controlled-release nifedipine (20-40 mg)
Trial: 16999056
Drug: Pharmacokinetically enhanced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacokinetically enhanced amoxicillin/clavulanate (2,000/125 mg) twice daily
Trial: 10691221
Drug: BFCN (bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BFCN (bupivacaine 2.5 mg, fentanyl 25 microg, clonidine 30 microg, neostigmine 10 microg)
Trial: 1858176
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg naproxen
Trial: 18564231
Drug: fesoterodine 4
RxNorm normalized name: fesoterodine 4 mg oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fesoterodine 4 mg